Background:A salivary gland tumor can enlarge either a major or small gland without causing any discomfort. Advances in preoperative and intraoperative diagnostics have reduced the invasiveness of surgically excising benign parotid gland tumors. Comparatively speaking, extracapsular dissection (ECD) has grown in popularity. There aren't many publications, nevertheless, on clinical results in the Indian population. Objective: To analyze the surgical results of ECD was the goal of this retrospective investigation. Methods: Thirty-six individuals who received treatment between 2017 and 2022 were gathered into a retrospective cohort. Demographic, clinical, and cost-effectiveness data were all documented. Results: An examination of the 36 instances of unilateral parotidectomy including ECD revealed that the duration of stay, anesthesia duration, and surgery time were all considerably reduced for ECD patients. The most frequent kind was pleomorphic adenoma, which was far more common to have positive margin status than Warthintumors. In 61.1% of ECD cases, the tumor' s near proximity exposed the facial nerve. Patients with ECD experienced fewer postoperative problems, such as temporary facial nerve paralysis and haemorrhage formation, which may indicate a reduced impact on their quality-of-life following surgery. There was no evidence of a recurrence. Conclusion:ECD is a viable treatment option for superficial benign parotid gland tumors following a thorough preoperative clinical, pathological, and radiological examination. ECD will probably result in fewer surgeries, anesthesia, and hospital stays, all of which will save costs.